Literature DB >> 20527233

The effects of genital schistosoma haematobium on human papillomavirus and the development of cervical neoplasia after five years in a Zimbabwean population.

E F Kjetland1, P D Ndhlovu, T Mduluza, V Deschoolmeester, N Midzi, E Gomo, L Gwanzura, P R Mason, J B Vermorken, H Friis, S G Gundersen, M F D Baay.   

Abstract

BACKGROUND: High-risk human papillomavirus (HPV) is responsible for cervical cancer and genital Schistosoma haematobium infection has been hypothesized to be an additional co-factor or even an independent risk factor for cervical neoplasia. The present study aimed to investigate the impact of schistosomiasis on HPV persistence and development of cell atypia in a group of rural Zimbabwean women with confirmed high-risk HPV.
METHODS: A five-year follow-up was done among women previously included in a study on genital schistosomiasis. Women who had high-risk HPV at baseline were invited after 5 years for examination of cell atypia, genital schistosomiasis, and high-risk HPV. Both vaginal lavage samples (low-cost) and cervix brush samples (high-cost) were obtained for further analysis.
RESULTS: Thirty-seven women were re-examined. Genital Schistosoma haematobium of a minimum of five years' duration was associated with the development high-grade squamous intraepithelial neoplasia, but not with persistent high-risk HPV. There was a high concordance between the brush and vaginal lavage (96.3% agreement, kappa 0.93); however, the number of beta-globin negative vaginal lavage samples was unacceptably high.
CONCLUSIONS: Findings warrant an exploration in a larger longitudinal study where a vaginal swab should be explored.

Entities:  

Mesh:

Year:  2010        PMID: 20527233

Source DB:  PubMed          Journal:  Eur J Gynaecol Oncol        ISSN: 0392-2936            Impact factor:   0.196


  11 in total

1.  Cervical cytology as a diagnostic tool for female genital schistosomiasis: Correlation to cervical atypia and Schistosoma polymerase chain reaction.

Authors:  Pavitra Pillay; Lisette van Lieshout; Myra Taylor; Motshedisi Sebitloane; Siphosenkosi Gift Zulu; Elisabeth Kleppa; Borghild Roald; Eyrun Floerecke Kjetland
Journal:  Cytojournal       Date:  2016-04-20       Impact factor: 2.091

Review 2.  Schistosomiasis in Nigeria: Gleaning from the past to improve current efforts towards control.

Authors:  Oyetunde Timothy Oyeyemi; Wander de Jesus Jeremias; Rafaella Fortini Queiroz Grenfell
Journal:  One Health       Date:  2020-10-14

3.  Rethinking the Top-Down Approach to Schistosomiasis Control and Elimination in Sub-Saharan Africa.

Authors:  Adeola Onasanya; Michel Bengtson; Oladimeji Oladepo; Jo Van Engelen; Jan Carel Diehl
Journal:  Front Public Health       Date:  2021-02-18

4.  Addressing a silent and neglected scourge in sexual and reproductive health in Sub-Saharan Africa by development of training competencies to improve prevention, diagnosis, and treatment of female genital schistosomiasis (FGS) for health workers.

Authors:  Julie Jacobson; Anastasia Pantelias; Megan Williamson; Eyrun Floerecke Kjetland; Alison Krentel; Margaret Gyapong; Pamela Sabina Mbabazi; Amadou Garba Djirmay
Journal:  Reprod Health       Date:  2022-01-24       Impact factor: 3.223

5.  Validation of the isothermal Schistosoma haematobium Recombinase Polymerase Amplification (RPA) assay, coupled with simplified sample preparation, for diagnosing female genital schistosomiasis using cervicovaginal lavage and vaginal self-swab samples.

Authors:  John Archer; Farhan K Patwary; Amy S Sturt; Emily L Webb; Comfort Rutty Phiri; Tobias Mweene; Richard J Hayes; Helen Ayles; Eric A T Brienen; Lisette van Lieshout; Bonnie L Webster; Amaya L Bustinduy
Journal:  PLoS Negl Trop Dis       Date:  2022-03-14

6.  A systematic review of handheld tools in lieu of colposcopy for cervical neoplasia and female genital schistosomiasis.

Authors:  Solrun Søfteland; Motshedisi Hannah Sebitloane; Myra Taylor; Borghild Barth Roald; Sigve Holmen; Hashini Nilushika Galappaththi-Arachchige; Svein Gunnar Gundersen; Eyrun Floerecke Kjetland
Journal:  Int J Gynaecol Obstet       Date:  2021-02-12       Impact factor: 3.561

7.  Eosinophil granule proteins ECP and EPX as markers for a potential early-stage inflammatory lesion in female genital schistosomiasis (FGS).

Authors:  Charles Emile Ramarokoto; Anna Overgaard Kildemoes; Bodo Sahondra Randrianasolo; Pascaline Ravoniarimbinina; Vololomboahangy Elisabeth Ravaoalimalala; Peter Leutscher; Eyrun Floerecke Kjetland; Birgitte Jyding Vennervald
Journal:  PLoS Negl Trop Dis       Date:  2014-07-17

8.  Integration of prevention and control measures for female genital schistosomiasis, HIV and cervical cancer.

Authors:  Dirk Engels; Peter J Hotez; Camilla Ducker; Margaret Gyapong; Amaya L Bustinduy; William E Secor; Wendy Harrison; Sally Theobald; Rachael Thomson; Victoria Gamba; Makia C Masong; Patrick Lammie; Kreeneshni Govender; Pamela S Mbabazi; Mwelecele N Malecela
Journal:  Bull World Health Organ       Date:  2020-07-06       Impact factor: 9.408

9.  High-risk HPV genotypes in Zimbabwean women with cervical cancer: Comparative analyses between HIV-negative and HIV-positive women.

Authors:  Oppah Kuguyo; Racheal S Dube Mandishora; Nicholas Ekow Thomford; Rudo Makunike-Mutasa; Charles F B Nhachi; Alice Matimba; Collet Dandara
Journal:  PLoS One       Date:  2021-09-28       Impact factor: 3.240

10.  Association between cervical dysplasia and female genital schistosomiasis diagnosed by genital PCR in Zambian women.

Authors:  H Rafferty; A S Sturt; C R Phiri; E L Webb; M Mudenda; J Mapani; P L A M Corstjens; G J van Dam; A Schaap; H Ayles; R J Hayes; L van Lieshout; I Hansingo; A L Bustinduy
Journal:  BMC Infect Dis       Date:  2021-07-17       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.